HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,650
+80 (0.59%)
Aug 28, 2025, 3:30 PM KST
0.59%
Market Cap191.68B
Revenue (ttm)36.10B
Net Income (ttm)472.66M
Shares Out14.04M
EPS (ttm)34.13
PE Ratio405.53
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume84,992
Average Volume118,117
Open13,520
Previous Close13,570
Day's Range13,500 - 13,820
52-Week Range13,290 - 33,250
Beta0.31
RSI29.12
Earnings Daten/a

About HLB Pharmaceutical

HLB Pharmaceutical Co., Ltd., a pharmaceutical company, researches and develops peptide drugs in South Korea. The company offers skeletal muscle relaxants, tranquilizers, antihistamines, antihypertensive agents, pain relief, antipruritics, astringents, anti-inflammatories, alimentary system drugs, metabolic drugs, ophthalmic agents, local anesthetics, antiarteriosclerotic agents, expectorants, antipyretics, analgesics, antidiabetic drug, chemotherapeutics, peptic ulcer agents, central nervous system drug, antibiotics, digestives, antacids, dent... [Read more]

Sector Healthcare
Founded 1998
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 047920
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.